• Go to navigation
  • Go to content
Seloken International

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca Cardiovascular

Main navigation

  • Home
  • The Product
  • Background
  • Ongoing Research
  • Slide Kits
  • Events
  • News
  • Webcasts
  • Press Releases
  • Feedback
  • Toolbox
  • Site map

You are here

  • Home
  • Press Releases

These articles are taken from the AstraZeneca Press Office. More information, images and data may be available to journalists at www.astrazenecapressoffice.com

Date

    • Jan 18, 2006
    • Toprol-XL® (metoprolol succinate): AstraZeneca to Appeal Decision in U.S. Patent Litigation   AstraZeneca today announced that it has received a decision of Judge Rodney Sippel of the U.S. District Court for the Eastern District of Missouri in litigation titled In Re Metoprolol Succinate Patent Litigation. This case is a consolidation of the company's cases against defendants KV Pharmaceutical Company, Andrx Pharmaceuticals LLC, Andrx Corporation, and Eon Labs Manufacturing, Inc.

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2008